Christine E McLaren Selected Research

Ferritins (Ferritin)

1/2019	Bivariate mixture models for the joint distribution of repeated serum ferritin and transferrin saturation measured 12 years apart in a cohort of healthy middle-aged Australians.
4/2017	HFE p.C282Y homozygosity predisposes to rapid serum ferritin rise after menopause: A genotype-stratified cohort study of hemochromatosis in Australian women.
4/2015	Natural history of HFE simple heterozygosity for C282Y and H63D: a prospective 12-year study.
7/2013	HFE mutations in Caucasian participants of the Hemochromatosis and Iron Overload Screening study with serum ferritin level <1000 µg/L.
7/2013	Association between celiac disease and iron deficiency in Caucasians, but not non-Caucasians.
6/2013	Telomere length and elevated iron: the influence of phenotype and HFE genotype.
6/2012	Probability of C282Y homozygosity decreases as liver transaminase activities increase in participants with hyperferritinemia in the hemochromatosis and iron overload screening study.
1/2012	Associations between single nucleotide polymorphisms in iron-related genes and iron status in multiethnic populations.
3/2011	Genome-wide association study identifies genetic loci associated with iron deficiency.
9/2010	HFE Cys282Tyr homozygotes with serum ferritin concentrations below 1000 microg/L are at low risk of hemochromatosis.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Christine E McLaren Research Topics

Disease

36	Hemochromatosis (Bronze Diabetes) 11/2020 - 02/2003
35	Iron Overload 11/2020 - 02/2003
10	Neoplasms (Cancer) 01/2020 - 03/2002
8	Adenoma (Adenomas) 01/2020 - 06/2008
7	Hyperferritinemia 08/2018 - 02/2007
4	Fibrosis (Cirrhosis) 08/2018 - 01/2008
4	Liver Diseases (Liver Disease) 05/2017 - 08/2007
4	Breast Neoplasms (Breast Cancer) 04/2017 - 10/2003
3	Iron Deficiencies 07/2013 - 03/2011
2	Sepsis (Septicemia) 09/2013 - 07/2013
2	Infections 09/2013 - 07/2013
2	Fetomaternal Transfusion 09/2013 - 07/2013
2	Ototoxicity 10/2010 - 12/2008
2	Fatigue 09/2010 - 01/2008
2	Arthritis (Polyarthritis) 09/2010 - 01/2008
2	Adenomatous Polyps 12/2008 - 06/2008
2	Skin Neoplasms (Skin Cancer) 12/2004 - 01/2003
2	Asthma (Bronchial Asthma) 06/2004 - 10/2002
1	Polyps 01/2020
1	Colorectal Neoplasms (Colorectal Cancer) 01/2020
1	Fatty Liver 08/2018
1	Hemorrhage 01/2018
1	Porphyria Cutanea Tarda 01/2016
1	type 2 Rhizomelic chondrodysplasia punctata 08/2015
1	Melanoma (Melanoma, Malignant) 05/2014
1	Nevus (Nevi) 05/2014
1	Residual Neoplasm 02/2014
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2014
1	Prostatic Neoplasms (Prostate Cancer) 01/2014
1	Atrophy 12/2013
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 03/2013
1	Hyperthermia 03/2013
1	Obesity 10/2012
1	Noninfiltrating Intraductal Carcinoma (DCIS) 06/2011
1	Hepatomegaly 09/2010
1	Diabetes Mellitus 09/2010
1	Hearing Loss (Hearing Impairment) 12/2008
1	Hepatocellular Carcinoma (Hepatoma) 01/2008
1	Joint Diseases (Joint Disease) 01/2008
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2008
1	Confusion (Bewilderment) 11/2007
1	Colonic Polyps 01/2006
1	Colonic Neoplasms (Colon Cancer) 01/2006
1	Actinic Keratosis 12/2004
1	Head and Neck Neoplasms (Head and Neck Cancer) 10/2004

Drug/Important Bio-Agent (IBA)

29	IronIBA 11/2020 - 02/2003
21	Ferritins (Ferritin)IBA 01/2019 - 01/2005
16	Transferrin (beta 2 Transferrin)IBA 01/2019 - 01/2005
7	Biomarkers (Surrogate Marker)IBA 04/2017 - 10/2003
5	Eflornithine (Ornidyl)FDA Link 10/2012 - 06/2008
5	Sulindac (Copal)FDA LinkGeneric 10/2010 - 06/2008
4	DNA (Deoxyribonucleic Acid)IBA 08/2015 - 02/2003
4	Pharmaceutical PreparationsIBA 09/2013 - 10/2002
3	AcyltransferasesIBA 11/2020 - 08/2015
3	PolyaminesIBA 10/2012 - 09/2010
2	Hemochromatosis ProteinIBA 01/2019 - 04/2015
2	Hemoglobins (Hemoglobin)IBA 01/2018 - 10/2007
2	metal transporting protein 1 (ferroportin)IBA 01/2018 - 05/2007
2	LipidsIBA 01/2018 - 05/2014
2	Equilibrative Nucleoside Transporter 1IBA 09/2013 - 07/2013
2	Transaminases (Aminotransferases)IBA 06/2012 - 01/2008
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2011 - 10/2003
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 10/2010 - 06/2008
2	PlacebosIBA 12/2008 - 06/2008
1	Metformin (Glucophage)FDA LinkGeneric 01/2020
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 08/2018
1	Alanine Transaminase (SGPT)IBA 08/2018
1	HepcidinsIBA 01/2018
1	deoxyhemoglobinIBA 01/2018
1	Hormones (Hormone)IBA 01/2018
1	Proteins (Proteins, Gene)FDA Link 01/2018
1	Indicators and Reagents (Reagents)IBA 05/2017
1	Tamoxifen FDA LinkGeneric 04/2017
1	Small Interfering RNA (siRNA)IBA 08/2015
1	Lovastatin (Mevacor)FDA LinkGeneric 05/2014
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2014
1	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2013
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2013
1	taxaneIBA 12/2013
1	OrnithineIBA 10/2010
1	Dinoprostone (PGE2)FDA Link 09/2010
1	EnzymesIBA 09/2010
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2010
1	Carrier Proteins (Binding Protein)IBA 03/2009
1	Heme (Haem)IBA 03/2009
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 03/2009
1	Immunomodulating AgentsIBA 01/2006
1	Levamisole (Decaris)FDA Link 01/2006
1	Biological ProductsIBA 12/2004

Therapy/Procedure

5	Chemoprevention 01/2014 - 01/2003
3	Therapeutics 01/2014 - 10/2002
3	Drug Therapy (Chemotherapy) 03/2013 - 10/2002
2	Neoadjuvant Therapy 04/2017 - 02/2014
2	Prostatectomy (Retropubic Prostatectomy) 01/2014 - 03/2002
2	Blood Component Removal (Apheresis) 09/2013 - 07/2013
2	Aftercare (After-Treatment) 10/2012 - 12/2008
1	Brachytherapy 03/2013
1	Immunomodulation 01/2006
1	Sutures (Suture) 10/2004
1	Immunotherapy 10/2004